ObjectivesTo assess the methodological quality of Chinese clinical practice guidelines (CPGs) for diagnosis and management of atrial fibrillation, and to provide methodological advice for developing and updating CPGs for atrial fibrillation in future. MethodsCBM, CNKI, WanFang Data and VIP databases were electronically searched to collect filter relevant CPGs from inception to Feburary, 2018. Two reviewers independently screened literature, extracted data and evaluated the quality of eligible CPGs by using the appraisal of guidelines for research and evaluation (AGREE Ⅱ) instrument. ResultsA total of 10 CPGs were included. The standardized mean scores for AGREE Ⅱ were: 54.17% for scope and purpose, 18.89% for stakeholder involvement, 15.89% for rigor of development, 66.39% for clarity and presentation, 34.9% for applicability, and 0 for editorial independence. ConclusionsThe quality of Chinese CPGs for atrial fibrillation is low. More efforts should be made to enhance the quality of CPGs for atrial fibrillation using methodological rigorous frameworks and strengthen guideline reporting.